Renal Disorder

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-02-16
Clinical Trial Update: Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213) [Phase 4]
Phase 4 trial update assessing antiproteinuric effects of losartan potassium in non-diabetic proteinuric renal diseases.